CELLADON CORP has a total of 32 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are MESOBLAST INTERNAT SARL, CHAPLIN PAUL and BARBER GLEN N.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Canada | 3 | |
#5 | Australia | 2 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | United Kingdom | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Foods and drinks | |
#5 | Organic fine chemistry | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Unspecified technologies | |
#5 | Enzymes | |
#6 | Heterocyclic compounds | |
#7 | Analysing materials | |
#8 | Peptides | |
#9 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zsebo Krisztina Maria | 14 |
#2 | Zsebo Krisztina M | 9 |
#3 | Senyei Andrew | 4 |
#4 | Hajjar Roger J | 3 |
#5 | Kawase Yoshiaki | 3 |
#6 | Zsebo Krisztina | 3 |
#7 | Ladage Dennis | 3 |
#8 | Dahl Russell | 2 |
#9 | Maria Zsebo Krisztina | 2 |
#10 | Cornea Razvan L | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016032569A1 | Quinolines and their use for treating endoplasmic reticulum stress-caused diseases | |
US2013287739A1 | Serca2 therapeutic compositions and methods of use | |
WO2011130552A2 | Serca2 therapeutic compositions and methods of use | |
US2011172144A1 | Methods for increasing expression of serca2a in cardiac muscle | |
WO2010088450A2 | Arylamide derivatives useful in the treatment of diseases associated with serca activity | |
WO2010085514A1 | Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban | |
KR20100129295A | Compositions for enhanced uptake of viral vectors in the myocardium | |
WO2008157031A1 | Serca2 therapeutic compositions and methods of use | |
CA2658628A1 | Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy |